1-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone, 95%, 1g

2-Methoxy-6-methylnicotinic acid, 98+%, 2g

{5-[1-(benzylamino)cyclohexyl]-1H-tetrazol-1-yl}acetic acid, 95.0%, 25g

1-(6-chloro-3-pyridinyl)-N,N-dimethylmethanamine, 95.0%, 5g

4-Bromophenacylamine hydrochloride, 95.0%, 500g

(R)-3-Ethynyl-3-hydroxy-1-methylpyrrolidin-2-one, 98%, 1g

6,7-Dihydro-4H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8(5H)-one, 95%, 250mg

N-(2-BROMO-5-CHLORO-4-METHYLPHENYL)ACETAMIDE, 95.0%, 5g

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 100 ml, glass packaging

5-Hydroxy-3,4-dihydroquinolin-2(1H)-one, 95.0%, 10g

tert-Butyl 4-(5-hydroxypyridin-2-yl)piperazine-1-carboxylate, 96%, 250mg

6-Amino-2-methyl-quinolin-4-ol, 500mg

Ethyl 2-cyanocyclopropanecarboxylate, 95.0%, 5g